Iridex (IRIX) Cash from Investing Activities (2011 - 2026)
Iridex's (IRIX) quarterly Cash from Investing Activities came in at -$101000.0 in Q2 2026, down 818.18% year-on-year from $14063.3 in Q2 2025, and up 4.72% quarter-over-quarter from -$106000.0 in Q1 2026.
Iridex (IRIX) Cash from Investing Activities (2011 - 2026) Analysis & Trends
Iridex's Cash from Investing Activities history runs 16 years deep, the most recent figure standing at -$101000.0 for Q2 2026.
- On a quarterly basis, Cash from Investing Activities fell 818.18% year-over-year to -$101000.0 in Q2 2026; TTM through Apr 2026 was -$233000.0, a 1009.52% decrease from a year earlier, with the FY2026 full-year figure at -$143000.0, down 1000.0% from the prior year.
- Cash from Investing Activities rose to -$101000.0 in Q2 2026 per IRIX's latest filing, from -$106000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $32000.0 in Q4 2023 and bottomed at -$5.5 million in Q1 2022.
- The 5-year median for Cash from Investing Activities is -$26000.0 (2022), against an average of -$360235.3.
- Across the five-year window, Cash from Investing Activities surged 138.55% in 2023 and tumbled 1200.0% in 2025, its largest moves.
- Year by year, Cash from Investing Activities stood at -$83000.0 in 2022, then jumped by 138.55% to $32000.0 in 2023, then plunged by 128.12% to -$9000.0 in 2024, then plunged by 44.44% to -$13000.0 in 2025, then tumbled by 676.92% to -$101000.0 in 2026.
- Per Business Quant, the three latest IRIX Cash from Investing Activities figures stand at -$101000.0 (Q2 2026), -$106000.0 (Q1 2026), and -$13000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.48 Bn | 176.19 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 129.11 Bn | 126.23 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 68.68 Bn | 67.22 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.67 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 28.38 Bn | 27.26 Bn | 750.30 Mn | -298.50 Mn |
| 7 | GE HealthCare Technologies | 28.04 Bn | 25.76 Bn | 1.98 Bn | -2.50 Bn |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | -475.32 Mn |
| 10 | Iridex | 15.39 Mn | 10.79 Mn | 4.74 Mn | -101,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -101,000.00 |
| Apr 4, 2026 | -101,000.00 |
| Jan 3, 2026 | -106,000.00 |
| Jan 3, 2026 | -106,000.00 |
| Sep 27, 2025 | -13,000.00 |
| Sep 27, 2025 | -13,000.00 |
| Jun 28, 2025 | -13,000.00 |
| Jun 28, 2025 | -13,000.00 |
| Mar 29, 2025 | -11,000.00 |
| Mar 29, 2025 | -11,000.00 |
| Dec 28, 2024 | -9,000.00 |
| Dec 28, 2024 | -9,000.00 |
| Sep 28, 2024 | -1,000.00 |
| Sep 28, 2024 | -1,000.00 |
| Mar 30, 2024 | -3,000.00 |
| Mar 30, 2024 | -3,000.00 |
| Dec 30, 2023 | 32,000.00 |
| Dec 30, 2023 | 32,000.00 |
| Sep 30, 2023 | -82,000.00 |
| Sep 30, 2023 | -82,000.00 |